Human data for BPC-157 is limited and low-certainty : Small case reports and pilot studies exist, including investigations into knee pain, but these do not rise to the level of large randomized controlled trials
As this class of medications becomes increasingly popular in the United States, it is important for providers to know which patients are at a higher or lower risk of developing acute pancreatitis after being started on them
This effectiveness must be correlated to the capacity to manage the molecular mechanisms underlying vascular function, metabolic equilibrium, and redox states through the intentional management of specific antioxidants (Sorriento et al., 2018)
However, the absence of FDA approval for any medical indication, limited large-scale trials, and variability in product formulations underscore the need for caution [10, 11]